Abstract:Background Although metastasis of clear cell renal cell carcinoma (ccRCC) is predominantly observed in late stage tumors, early stage metastasis of ccRCC can also be found with indefinite molecular mechanism, leading to inappropriate clinical decisions and poor prognosis. Stanniocalcin-1 (STC1) is a glycoprotein hormone involved in calcium/phosphate homeostasis, which regulates various cellular processes in normal development and tumorigenesis. This study aimed to investigate the role and mechanism of regulation of STC1 in the metastasis of early stage ccRCC. Methods STC1 mRNA and protein expression was determined in ccRCC surgical specimens, RCC cell lines, and human kidney tubule epithelial cell line HKC by real-time polymerase chain reaction (RT-PCR) and western blotting. Immunohistochemistry staining (IHC) and immunofluorescence were also used to examine the expression and localization of STC1 in ccRCC tissues and cancer cells. Knockdown and overexpression studies were conducted in vitro in RCC cell lines using small interfering RNAs (siRNA) and lentiviral-mediated gene delivery to evaluate the role of STC1 in cell proliferation, anchorage-dependent and independent growth, cell cycle control, and migration and invasion. Results STC1 mRNA and protein expression were significantly up-regulated in tumors when compared with non-tumor tissues, with the greatest increase in expression observed in metastatic tissues. Clinicopathological analysis revealed that STC1 mRNA expression was associated with Fuhrman tumor grade ( P = 0.008) and overall Tumor Node Metastasis (TNM) staging ( P = 0.018). STC1 expression was elevated in T1 stage metastatic tumors when compared with localized tumors, and was positively correlated with average tumor diameter. Silencing of STC1 expression by Caki-1 and A498 resulted in the inhibition of cell proliferation, migration, and invasion, meanwhile down-regulation of STC1 impaired epithelial–mesenchymal transition (EMT) of ccRCC cell lines. Overexpression of STC1 in Caki-2 enhanced cell growth and proliferation but not migration and invasion. Further investigation identified hypoxia and HIF-1α as candidate regulators of STC1 expression. Conclusions Our findings demonstrate a role for STC1 in metastasis of early stage ccRCC and suggest that STC1 may be a biomarker of potential value both for the prognosis of this disease and for guiding clinical decisions regarding surgical strategies and adjuvant treatment.

STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma

Stromal Interaction Molecule 1/microtubule‐associated Protein 1a/1b‐light Chain 3B Complex Induces Metastasis of Hepatocellular Carcinoma by Promoting Autophagy

STIM1 Mediates Hypoxia-Driven Hepatocarcinogenesis Via Interaction with HIF-1.

SIRT1 Facilitates Hepatocellular Carcinoma Metastasis by Promoting PGC-1α-mediated Mitochondrial Biogenesis.

STIP1 is Over-Expressed in Hepatocellular Carcinoma and Promotes the Growth and Migration of Cancer Cells.

Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation

Suppression of Stromal Interaction Molecule 1 Inhibits SMMC7721 Hepatocellular Carcinoma Cell Proliferation by Inducing Cell Cycle Arrest.

The Stromal-Tumor Amplifying STC1-Notch1 Feedforward Signal Promotes the Stemness of Hepatocellular Carcinoma

STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway

The Roles and Mechanism of STIM1 in Tumorigenesis and Metastasis

Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma

Blocking of Stromal Interaction Molecule 1 Expression Influence Cell Proliferation and Promote Cell Apoptosis in Vitro and Inhibit Tumor Growth in Vivo in Head and Neck Squamous Cell Carcinoma

STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β‐catenin signaling pathway

STIM1, a Direct Target of Microrna-185, Promotes Tumor Metastasis and is Associated with Poor Prognosis in Colorectal Cancer.

Knockdown of STIM1 Expression Inhibits Non-Small-cell Lung Cancer Cell Proliferation in Vitro and in Nude Mouse Xenografts.

STIM1 Accelerates Cell Senescence in a Remodeled Microenvironment but Enhances the Epithelial-to-mesenchymal Transition in Prostate Cancer

STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway

HSF1 Promotes the Inhibition of EMT-associated Migration by Low Glucose Via Directly Regulating Snail1 Expression in HCC Cells.

Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma

Metabolism-Induced Tumor Activator 1 (Mita1), An Energy Stress-Inducible Long Noncoding Rna, Promotes Hepatocellular Carcinoma Metastasis

ATP6V1D drives hepatocellular carcinoma stemness and progression via both lysosome acidification-dependent and -independent mechanisms